Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
23.36B
Market cap23.36B
Price-Earnings ratio
24.24
Price-Earnings ratio24.24
Dividend yield
1.51%
Dividend yield1.51%
Average volume
896.12K
Average volume896.12K
High today
$213.26
High today$213.26
Low today
$211.86
Low today$211.86
Open price
$212.13
Open price$212.13
Volume
69.47K
Volume69.47K
52 Week high
$213.50
52 Week high$213.50
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

The current Quest Diagnostics(DGX) stock price is $212.63, with a market capitalization of 23.36B. The stock trades at a price-to-earnings (P/E) ratio of 24.24 and offers a dividend yield of 1.5%.

As of 2026-03-02, Quest Diagnostics(DGX) stock has fluctuated between $211.86 and $213.26. The current price stands at $212.63, placing the stock +0.4% above today's low and -0.3% off the high.

Quest Diagnostics(DGX) shares are trading with a volume of 69.47K, against a daily average of 896.12K.

During the past year, Quest Diagnostics(DGX) stock moved between $157.20 at its lowest and $213.50 at its peak.

During the past year, Quest Diagnostics(DGX) stock moved between $157.20 at its lowest and $213.50 at its peak.

DGX News

Simply Wall St 2d
A Look At Quest Diagnostics Valuation After Recent Share Price Momentum

Advertisement Why Quest Diagnostics is on investors’ radar today Quest Diagnostics (DGX) is drawing attention after recent share price moves, with the stock l...

A Look At Quest Diagnostics Valuation After Recent Share Price Momentum
TipRanks 4d
Quest Diagnostics names Benjamin Beauvalot VP, Chief Strategy and M&A Officer

Quest Diagnostics (DGX) announced that Benjamin Beauvalot has joined the company as SVP, Chief Strategy and M&A Officer. Prior to joining Quest, Beauvalot held...

Simply Wall St 6d
How Investors May Respond To Quest Diagnostics Earnings Beat, Higher Dividend And Expansion Plans

In February 2026, Quest Diagnostics reported higher fourth-quarter and full-year 2025 sales and earnings, issued 2026 guidance calling for US$11.70–US$11.82 bil...

How Investors May Respond To Quest Diagnostics Earnings Beat, Higher Dividend And Expansion Plans

Analyst ratings

52%

of 21 ratings
Buy
42.9%
Hold
52.4%
Sell
4.8%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.